Yabe Hiromasa, Inoue Hiroyasu, Matsumoto Masae, Hamanoue Satoshi, Koike Takashi, Ishiguro Hiroyuki, Koike Hideki, Suzuki Kazuo, Kato Shunichi, Kojima Seiji, Tsuchida Masahiro, Mori Tetsuya, Adachi Souichi, Tsuji Koichiro, Koike Kenichi, Morimoto Akira, Sako Masahiro, Yabe Miharu
Specialized Clinical Science, Pediatrics, Tokai University School of Medicine, Isehara, Japan.
Br J Haematol. 2006 Jul;134(2):208-12. doi: 10.1111/j.1365-2141.2006.06128.x.
A pilot study was undertaken using a fludarabine-based conditioning regimen to improve haematopoietic cell transplantation (HCT) from alternative donors in 27 Fanconi anaemia (FA) patients. Patients were conditioned with 150-180 mg/m2 of fludarabine, 40 mg/kg of cyclophosphamide, 5-10 mg/kg of antithymocyte globulin, and 300-450 cGy of thoracoabdominal/total body irradiation. One patient who received unrelated cord blood transplantation failed to engraft, another patient died of sepsis. The 1-year overall survival was 96.3% (95% CI, 89-100). This conditioning regimen exerted an immunosuppressive effect that enabled durable engraftment in alternative donor HCT without severe toxicity.
开展了一项初步研究,对27例范可尼贫血(FA)患者采用基于氟达拉滨的预处理方案,以改善来自替代供者的造血细胞移植(HCT)。患者接受150 - 180 mg/m²氟达拉滨、40 mg/kg环磷酰胺、5 - 10 mg/kg抗胸腺细胞球蛋白以及300 - 450 cGy胸腹部/全身照射进行预处理。1例接受非血缘脐血移植的患者未实现植入,另1例患者死于败血症。1年总生存率为96.3%(95%CI,89 - 100)。该预处理方案发挥了免疫抑制作用,使得在替代供者HCT中能够实现持久植入且无严重毒性。